CYTOKINETICS, INCORPORATED Total Liabilities and Equity
CYTOKINETICS, INCORPORATED (CYTK) had Total Liabilities and Equity of $1.92 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $1.92B.
- 2026-03-31: Liabilities and Equity $1.27B.
- 2025-12-31: Liabilities and Equity $1.42B.
- 2025-09-30: Liabilities and Equity $1.44B.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $1.92B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.27B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.42B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.44B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.23B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.26B 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.40B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.44B 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.52B 10-Q · filed 2024-08-09 |
| 2024-03-31 | $808.08M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $824.32M 10-K · filed 2025-02-27 |
| 2023-09-30 | $740.61M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $779.90M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $889.82M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.01B 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.08B 10-Q · filed 2022-11-04 |
| 2022-06-30 | $771.72M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $856.25M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $841.32M 10-K · filed 2023-03-01 |
| 2021-09-30 | $827.54M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $564.30M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $577.06M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $533.80M 10-K · filed 2022-02-25 |
| 2020-09-30 | $474.11M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $232.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $256.58M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $289.81M 10-K · filed 2021-02-26 |
| 2019-09-30 | $187.39M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $198.22M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $198.61M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $211.18M 10-K · filed 2020-03-04 |
| 2018-09-30 | $230.28M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $247.24M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $279.93M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $294.81M 10-K · filed 2019-03-07 |
| 2017-09-30 | $326.31M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $340.63M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $265.37M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $170.14M 10-K · filed 2018-03-05 |
| 2016-09-30 | $158.17M 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $106.16M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $113.22M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $115.24M 10-K · filed 2017-03-06 |
| 2015-09-30 | $102.20M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $112.71M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $122.21M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $132.97M 10-K · filed 2016-03-03 |
| 2014-09-30 | $87.19M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $96.14M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $107.28M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $83.19M 10-K · filed 2015-03-06 |
| 2013-09-30 | $88.01M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $94.56M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $64.69M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $77.55M 10-K · filed 2014-03-07 |
| 2012-09-30 | $85.34M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $94.08M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $46.53M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $52.77M 10-K · filed 2013-03-15 |
| 2011-09-30 | $61.78M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $72.16M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $77.99M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |